SCH 50911   Click here for help

GtoPdb Ligand ID: 1075

Synonyms: SCH-50911 | SCH50911
PDB Ligand
Compound class: Synthetic organic
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 2
Rotatable bonds 2
Topological polar surface area 58.56
Molecular weight 173.11
XLogP -0.12
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OC(=O)CC1OCC(NC1)(C)C
Isomeric SMILES OC(=O)C[C@@H]1OCC(NC1)(C)C
InChI InChI=1S/C8H15NO3/c1-8(2)5-12-6(4-9-8)3-7(10)11/h6,9H,3-5H2,1-2H3,(H,10,11)/t6-/m0/s1
InChI Key SEYCKMQSPUVYEF-LURJTMIESA-N
References
1. Bolser DC, Blythin DJ, Chapman RW, Egan RW, Hey JA, Rizzo C, Kuo SC, Kreutner W. (1995)
The pharmacology of SCH 50911: a novel, orally-active GABA-beta receptor antagonist.
J Pharmacol Exp Ther, 274 (3): 1393-8. [PMID:7562513]
2. Hirst WD, Babbs AJ, Green A, Minton JA, Shaw TE, Wise A, Rice SQ, Pangalos MN, Price GW. (2003)
Pharmacological characterisation of a cell line expressing GABA B1b and GABA B2 receptor subunits.
Biochem Pharmacol, 65 (7): 1103-13. [PMID:12663046]
3. Wood MD, Murkitt KL, Rice SQ, Testa T, Punia PK, Stammers M, Jenkins O, Elshourbagy NA, Shabon U, Taylor SJ et al.. (2000)
The human GABA(B1b) and GABA(B2) heterodimeric recombinant receptor shows low sensitivity to phaclofen and saclofen.
Br J Pharmacol, 131 (6): 1050-4. [PMID:11082110]